about abs

American Brachytherapy Society Fact Sheet

Society Contact

Melissa Pomerene
Executive Director
P: 703-234-4077, extension 4085






The purpose of the ABS is to serve its members by advancing the field of Brachytherapy, by promoting excellence in education, research and clinical practice, and by representing Brachytherapy specialists and their patients.



The ABS provides multiple resources for different audiences. For the professional community, the ABS offers a peer-reviewed journal, Brachytherapy, medical education opportunities, a "members only" newsletter, as well as a forum for discussion held at the annual conference. For the consumer, the ABS has a consumer-friendly website that is designed to offer easy-to-understand explanations of the practice, history, and applications of brachytherapy.


President: Brett W. Cox, MD
President-Elect: Mira Keyes, MD, FABS
Vice President: MItchell Kamrava, MD
Treasurer: Kristin Bradley, MD
Secretary: Junzo Chino, MD
Directors at Large:

Christine Fisher, MD
Marisa Kollmeier, MD
Christopher Deufel, PhD
Jyoti Mayadev, MD

Chairman: Peter J. Rossi, MD, FABS
Past Chairman: Ann Klopp, MD, PhD



Currently, brachytherapy is being used primarily to treat prostate, breast, and cervical cancers. Because it is much less invasive than surgery and less disruptive to the patient, brachytherapy offers appropriate patients an effective alternative. The American Cancer Society estimates that there will be:

  • 288,300 new cases of prostate cancer and 34,700 deaths due to prostate cancer in 2024 ( Since 2014, however, the incidence rate has increased by 3% per year overall and by about 5% per year for advanced-stage prostate cancer). Prostate cancer is the second leading cause of cancer death in men.
  • 287,850 new cases of breast cancer and 43,250 deaths due to breast cancer in 2024.
  • 12,710 new cases of cervical cancer, and 4,290 deaths due to cervical cancer in 2024.


About The American Brachytherapy Society

The American Brachytherapy Society was founded in 1978 to provide insight, rationale, and research into the use of brachytherapy in the treatment of both malignant and benign conditions. The organization consists of physicians, physicists, and others interested in brachytherapy.